Search Within

Howard Scher

Formats
  1. Journal Article (626)
  2. Meeting Abstract (463)
  3. Book Section (13)
  4. Conference Paper (11)
  5. Editorial (7)
  6. Review (6)
  7. Guidelines (3)
  8. Correspondence (2)
  9. Research Letter (2)
Groups
  1. Department of Medicine (1133)
  2. Genitourinary Oncology Service (1133)
  3. Solid Tumor Oncology Division (1133)
  4. GSK Faculty (305)
  5. Sloan Kettering Institute Faculty (249)
  6. Department of Pathology and Laboratory Medicine (241)

More Groups

People
  1. Michael Morris (217)
  2. Susan Slovin (140)
  3. Dana Rathkopf (133)
  4. Daniel Danila (112)
  5. Steven Larson (110)
  6. Victor Reuter (97)

More People

Years
  1. 2025 (11)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (25)
  5. 2021 (19)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (328)
  2. Clinical Cancer Research (85)
  3. Cancer Research (54)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (47)
  5. Journal of Urology (36)
  6. European Urology (35)

More Publications

Publishers
  1. American Society of Clinical Oncology (335)
  2. American Association for Cancer Research (197)
  3. Elsevier Science, Inc. (119)
  4. Elsevier Inc. (72)
  5. Nature Publishing Group (58)
  6. Oxford University Press (47)

More Publishers

Results (1133)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Leversha, M. A.; Gonzalez-Espinoza, R.; Anand, A.; Gu, B.; Gignac, G. A.; Larson, S.; Heller, G.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Long-term toxicity monitoring via electronic patient reported outcomes in end-stage chemotherapy patients
    Meeting Abstract

    Basch, E. M.; Iasonos, A.; Barz, A.; Culkin, A.; Kris, M. G.; Artz, D.; Fearn, P.; Speakman, J.; Scher, H. I.; Schrag, D.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • The clinical state of the rising PSA level after definitive local therapy: A practical approach
    Book Section

    Morris, M. J.; Scher, H. I.
    In Wein, A. J.; Kavoussi, L. R.; Novick, A. C.; Partin, A. W.; Peters, C. A. (Eds.) Campbell-Walsh Urology. 9th ed (2007)

    Fulltext@MSK | Save
  • Circulating angiogenic cells in metastatic prostate cancer: Assessment of the bone marrow vascular and peripheral blood vascular compartments
    Meeting Abstract

    Seandel, M.; Fleisher, M.; Hooper, A. T.; Rafii, S.; Scher, H. I.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • PCK3145, a novel multitargeted signalling agent for the treatment of castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Dulude, H.; Pancha, C.; Czanny, M.; Curley, T.; Morris, M.; Rathkopf, D.; Schwartz, L.; Heller, G.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Circulating tumor cells as prognostic biomarkers in patients with metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Heller, G.; Leversha, M. A.; Lilja, H.; Gonzalez-Espinoza, R.; Anand, A.; Larson, S.; Schwartz, L. H.; Fleisher, M.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Phase I dose-escalation study of AGS-PSCA, an anti-PSCA human antibody, in castration-resistant prostate cancer
    Meeting Abstract

    Carducci, M. A.; Morris, M. J.; Eisenberger, M. A.; Pili, R.; Denmeade, S. R.; Slovin, S. F.; Kelsen, M.; Jacobovits, A.; Vincent, M.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Structural model selection for 17-DMAG, a comparison of helrarchical bayesian approaches (PKBUGS) and frequentist adaptations of this approach in nonmem and PDX-MCPEM
    Meeting Abstract

    Bies, R. R.; Guzy, S.; Ramanathan, R. K.; Belani, C. P.; Solit, B.; Scher, H. I.; Holleran, J. L.; Ivy, P. S.; Egorin, M. J.
    Clinical Pharmacology & Therapeutics (2007)

    Fulltext@MSK | Save
  • Prostate specific membrane antigen (PSMA) expression in primary prostatic adenocarcinoma: Comparison of expression with gleason grade and hormonal therapy
    Meeting Abstract

    Al-Ahmadie, H. A.; Prakash, S.; Gopalan, A.; Olgac, S.; Tickoo, S. K.; Fine, S. W.; Scher, H. I.; Reuter, V. E.
    Laboratory Investigation (2007)

    Fulltext@MSK | Save
  • Prostate specific membrane antigen (PSMA) expression in primary prostatic adenocarcinoma: Comparison of expression with gleason grade and hormonal therapy
    Meeting Abstract

    Al-Ahmadie, H. A.; Prakash, S.; Gopalan, A.; Olgac, S.; Tickoo, S. K.; Fine, S. W.; Scher, H. I.; Reuter, V. E.
    Modern Pathology (2007)

    Fulltext@MSK | Save